Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Convertible Debt: 2011-2012

Historic Convertible Debt for UNITED THERAPEUTICS (UTHR) over the last 2 years, with Dec 2012 value amounting to $204.7 million.

  • UNITED THERAPEUTICS's Convertible Debt rose 5.41% to $207.4 million in Q1 2013 from the same period last year, while for Mar 2013 it was $207.4 million, marking a year-over-year increase of 5.41%. This contributed to the annual value of $204.7 million for FY2012, which is 5.40% up from last year.
  • According to the latest figures from FY2012, UNITED THERAPEUTICS's Convertible Debt is $204.7 million, which was up 5.40% from $194.2 million recorded in FY2011.
  • UNITED THERAPEUTICS's Convertible Debt's 5-year high stood at $204.7 million during FY2012, with a 5-year trough of $194.2 million in FY2011.
  • In the last 2 years, UNITED THERAPEUTICS's Convertible Debt had a median value of $199.4 million in 2011 and averaged $199.4 million.
  • Data for UNITED THERAPEUTICS's Convertible Debt shows a peak YoY rose of 5.40% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows UNITED THERAPEUTICS's Convertible Debt stood at $194.2 million in 2011, then rose by 5.40% to $204.7 million in 2012.